
Sign up to save your podcasts
Or
Stereotaxis is developing robotic capabilities to enhance procedures for treating atrial fibrillation, with several innovations in the works. In this Vanguards of Health Care podcast episode, CEO David Fischel sits down with Bloomberg Intelligence analyst Matt Henriksson for a discussion about how the company’s Robotic Navigation System helps patients and future prospects for the use of robotics in cardiology surgery.
See omnystudio.com/listener for privacy information.
5
22 ratings
Stereotaxis is developing robotic capabilities to enhance procedures for treating atrial fibrillation, with several innovations in the works. In this Vanguards of Health Care podcast episode, CEO David Fischel sits down with Bloomberg Intelligence analyst Matt Henriksson for a discussion about how the company’s Robotic Navigation System helps patients and future prospects for the use of robotics in cardiology surgery.
See omnystudio.com/listener for privacy information.
1,199 Listeners
2,174 Listeners
1,784 Listeners
394 Listeners
122 Listeners
774 Listeners
91 Listeners
9,189 Listeners
147 Listeners
246 Listeners
15,237 Listeners
351 Listeners
17 Listeners
461 Listeners
371 Listeners